Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677

BACKGROUND: The prognosis for patients with recurrent glioblastoma remains poor. The purpose of this study was to assess the potential role of MR spectroscopy as an early indicator of response to anti-angiogenic therapy. METHODS: Thirteen patients with recurrent glioblastoma were enrolled in RTOG 06...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Ratai, Eva-Maria, Zhang, Zheng, Snyder, Bradley S., Boxerman, Jerrold L., Safriel, Yair, McKinstry, Robert C., Bokstein, Felix, Gilbert, Mark R., Sorensen, A. Gregory, Barboriak, Daniel P.
التنسيق: Artigo
اللغة:Inglês
منشور في: Oxford University Press 2013
الموضوعات:
Clinical Investigations
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3688017/
https://ncbi.nlm.nih.gov/pubmed/23645534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/not044
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة